Effect of Intravenous or Intrathecal Dexmedetomidine on Bupivacaine Spinal Block in Lower Abdominal Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 2, 2022

Primary Completion Date

December 30, 2023

Study Completion Date

March 10, 2024

Conditions
Spinal Anesthetics Causing Adverse Effects in Therapeutic Use
Interventions
DRUG

Dexmedetomidine

"Under a sterile technique, spinal anesthesia will be carried out using a 22-G Quincke spinal needle after skin infiltration with 2% lidocaine 3 ml a t the L3-L4 level, a midline approach in the sitting position, and then in the supine position.~Th e time of spinal injection will be considered time zero (T0). The I.V drug regimen will be started according to the group to which patients will be assigned.patients will receive intrathecal 15 mg hyperbaric bupivacaine together with 5 μg Dexmedetomidine in group 2"

Trial Locations (1)

71111

Azhar University, Asyut

All Listed Sponsors
lead

Al-Azhar University

OTHER

NCT06654531 - Effect of Intravenous or Intrathecal Dexmedetomidine on Bupivacaine Spinal Block in Lower Abdominal Surgery | Biotech Hunter | Biotech Hunter